Leveraging Next-Generation Sequencing Application from Identity to Purity Profiling of Nucleic Acid-Based Products
<b>Background/Objectives</b>: The nucleic acid-based product (NAP) portfolio is expanding continuously and provides safer curative options for many disease indications. Nucleic acid-based products offer several advantages compared to proteins and virus-based products. They represent an e...
Saved in:
| Main Authors: | Rucha Wadapurkar, Swarda Deo, Renuka Khanzode, Ajay Singh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/1/30 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nucleic acid vaccines: innovations, efficacy, and applications in at-risk populations
by: Emily N. Konopka, et al.
Published: (2025-05-01) -
Advanced Nanotechnology-Based Nucleic Acid Medicines
by: Noriko Miyamoto, et al.
Published: (2024-10-01) -
Development of nucleic acid-based vaccines against dengue and other mosquito-borne flaviviruses: the past, present, and future
by: Muhammad Bashir Bello, et al.
Published: (2025-01-01) -
Advances in nucleic acid-based cancer vaccines
by: Hung-Chun Liao, et al.
Published: (2025-01-01) -
Circular RNA vaccines: Pioneering the next-gen cancer immunotherapy
by: Uddalak Das, et al.
Published: (2025-07-01)